No it may be because it has never been a great indicator. RIG has 70% institutional ownership. I can give you lots of examples. In biotechs lots of groupies follow Fido and T Rowe...Not a big deal. The institutions are not right all the time.
Others in the cessation market focus on pills like Chantix which is having a problem with suicides. Do some work and look at XXII's patent estate. We own it for all intents and purposes. What no one talks about here is the mark up in the smoking market. Do you know what it costs MO to make one pack of Marlboros???
I drink non-alchoholic beer..Tastes the same..As a reformed drinker I find it gives me the flavor but not the addiction...The cigarettes these guys make are going to find a huge market.
Your are an idiot. I can't wait for nicotine free chewing tobacco....I smoke cuban cigars. I do not inhale them. I enjoy the smell and taste of tobacco.
By the way, what does nicotine taste like???? Maybe we should start a new drink made from nicotine...Get a life
Noise and low dollar priced stocks are all victims. I do not know how they make money.
.....and there is a great story about knee replacements and obesity. There was a recommendation by an surgeon for a patient to get bariatric before a knee replacement but the patient refused. Obesity is the orthopaedic surgeons best friend as the feet, knees and hips were not made for the over weight person. This is going to be an inducement for the insurers to cover VBLOC. The medical savings down the line are huge. We hear Knudson et al talk about the comorbidities associated with obesity. The damage to the body's frame is just as bad and maybe worse.
Their costs on the plant..See the income statement..They lose money. Last time I talked to the company they wanted out....And I was never short..I was long and now I have no position.
Rigdon is a dreamer but a nice guy. What ever they do it will take years to be profitable, but in today's market that must not be a criteria. I just wish they got capital from another source. They shares trading up now are being sold by the folks that just bought them. RSI high. Good luck.
They do not get any special treatment as material events must be disclosed to all shareholders.
And the buyers would never sign a CDA. The inducement? A 10% discount to the market. All I know is averaging down killed more people than Hitler. They have a deal they were obligated to disclose it to all shareholders, and seeing the buyers were shareholders they go no special info.
That is against the law.
Hey good luck guys...If they got GE money as an investment or a deal I would stay on board. Be that Rigdon has worn me out with his promises I hope you guys make some money.
Big pharma is getting out of R&D and buying companies. Device industry is no different. After Medtronics and Covidien sees how the VBLOC roll out is they will be knocking at the door for an international deal. I suspect the Japanese will also be sniffing. In 2000 Pfizer could have bought 50% of the biotech industry for what they spent on R&D. The CSOs of all the big pharma companies sold bills of goods to the Boards. When PFE fired the inventor of Lipitor I knew the tide had turned. Look at the IBB. Why do you think it is there? Device companies have it a lot better as side effects and price work in their favor.
But a great article and thanks for sharing.
Like the CEO taking stock instead of cash....They have promised traction for so long I have tread marks on my back. I will revisit if they ever get anything solid. I can't believe they have not made a deal in Pakistan Worst electric grif in the world and they have nukes.
What are you smoking..No deal dilution..The same Rigdon manure...They can't get anything done so now they get the market to pay salaries for another year. I sold this POS...Energy is getting too cheap and Russia will give the chinese et al all the gas they need.....Check the methanol market smart guy
Gary ... We just got this device approved and the people who debase the process ignore all the things that make ETRM great investment. I love the technology. Electroceuticals or whatever the market wants to call them are going to be big or bigger than a lot of the risks that are on biotech drawing boards. For me the company was just too smart for their own good and thought the approval would boost the price a lot higher. But that is OK..I think they are finding demand much higher from the medical side and they have the patients. With bariatrics leveling out they need VBLOC. What isn't leveling out is obesity. it is getting worse. The company knows where they are and are adding great people.
But this stock is going to do well and once we get rid of the static. I still can't get over the fact this is a $1.16 stock and it has huge volume and a load of bashers.
They are speculators and will cover at days end if they can't buy your shares. Borrowing cost is still high..They know nothing you don't. Only they understand risk.
My guess is they do a convert ..maybe 20 million after the earnings call. They seem now more prepared to give the market updates on their roll out. I imagine they are now over 25 centers and have had two to three classes of surgeon training so that number may also be revised to 40 ish.
If as someone said they are revamping their website, they may start to list the centers and the surgeons which would really help. My email continues to get Google alerts on obesity.
I have no plans to sell my stock any time soon as I suspect VBLOC is still a ways away from general acceptance. I also want to see a domestic collaboration with someone like GSK and then an international deal, but that is down the road. I still think the market gives us no value for our patent estate and technology. .....They will
Kis...The only sad part of the ETRM story is too many bashers and ones with negative analysis look short term. If they did some research they would see bariatric surgeries have leveled off since 2010 but the number of bariatric surgeons have increased. There are people who think the number of centers will almost stop at 40-50 and the number of trained docs will level off. They believe insurance reimbursement will never occur. I imagine at the end of 2016 we could have 200 centers 500 trained surgeons. The company as we see has not been static and the only #$%$ in their armor is not enough capital. They are addressing that. We have the possibility of seeing exponential growth. How many hospitals are there and how many surgeons are there? If people took the time to reread the minutes form the ADCOM meeting they would see the number of societies who testified on our behalf and how large those groups were.
I think the number of centers and doctors could surprise by year end and with Sikora joining in June he could make a huge difference. I believe Hancock and his sales guys are doing a great job and we will know more in May. We can't quantify demand presently but common sense dictates it has to be substantial. Again, I hope for some clarity at the earnings call.
The international deal is of course ea concern, as is a collaboration with a major drug company using our technology. That said, I think resources are all concentrated on our domestic growth which it should be.